pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - 4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 74 contracts
Samples: Exclusive License Agreement (Metabolix, Inc.), Call Option Agreement (Isis Pharmaceuticals Inc), Distribution Agreement (Blue Gem Enterprise)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - 4(d), no discovery shall be required or permitted by any means, including depositionsdeposition, interrogatories, requests for admissions, admissions or production of documents.
Appears in 12 contracts
Samples: Agreement Regarding Change in Control (Hospira Inc), Agreement Regarding Change in Control (Hospira Inc), Agreement Regarding Change in Control (Hospira Inc)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - 4(d4(a)-4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 9 contracts
Samples: License Agreement (Neurobiological Technologies Inc /Ca/), License Agreement (Neurobiological Technologies Inc /Ca/), Distribution Agreement (Heska Corp)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - – 4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 8 contracts
Samples: Manufacturing Agreement (Reliant Pharmaceuticals, Inc.), Manufacturing Agreement (Reliant Pharmaceuticals, Inc.), Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(aD(a) - 4(dD(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 6 contracts
Samples: Research Agreement (Ribogene Inc / Ca/), Research Agreement (Ribogene Inc / Ca/), 5 Research Agreement (Ribogene Inc / Ca/)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - — 4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 4 contracts
Samples: Supply Agreement (Martek Biosciences Corp), Agreement (Arqule Inc), Confidential Treatment (Kadmon Holdings, LLC)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - 4(d)) above, no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 4 contracts
Samples: License Agreement (Aronex Pharmaceuticals Inc), License Agreement (Abbott Laboratories), Stock Purchase Agreement (Abbott Laboratories)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - 4(d)) of this Exhibit G and except with respect to Section 5 of the Agreement, no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 3 contracts
Samples: License Agreement (Santarus Inc), License Agreement (Santarus Inc), License Agreement (Santarus Inc)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - 4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 3 contracts
Samples: Collaborative Development Agreement (Health Enhancement Products Inc), Collaborative Development Agreement (HEPI Pharmaceuticals, Inc.), Exclusive License Agreement (American Biogenetic Sciences Inc)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - 4(d)) or as may be permitted by the neutral upon a showing of good cause, no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 3 contracts
Samples: License Agreement (Arcadia Biosciences, Inc.), License Agreement (Arcadia Biosciences, Inc.), License Agreement (Arcadia Biosciences, Inc.)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(aSections 17.5(a) - 4(d17.5(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 3 contracts
Samples: Sublicense Agreement (Calypte Biomedical Corp), Sublicense Agreement (Calypte Biomedical Corp), Sublicense Agreement (Matritech Inc/De/)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs subsections 4(a) - 4(d), no discovery shall be required or permitted by any means, including depositionsdeposition, interrogatories, requests for admissions, admissions or production of documents.
Appears in 3 contracts
Samples: Form Of (Abbott Laboratories), Agreement Regarding Change in Control (AbbVie Inc.), Agreement Regarding (Abbott Laboratories)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - 4(d4(a)-(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 2 contracts
Samples: Collaboration and License Agreement (Millennium Pharmaceuticals Inc), And Development Agreement (Millennium Pharmaceuticals Inc)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceedingproceeding but may be amended by the neutral to the extent required to justly resolve the disputes related thereto. Except as expressly set forth in subparagraphs 4(a) - 4(d4(a)—4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 2 contracts
Samples: Healthetech Inc, Healthetech Inc
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - 4(a)- 4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 2 contracts
Samples: Exclusive License and Development Agreement (Rubicon Medical Inc), Exclusive License and Development Agreement (Rubicon Medical Inc)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - 4(d), no discovery shall be required or permitted by any means, including depositions, interrogatoriesinterrogations, requests request for admissions, admissions or production of documents.
Appears in 2 contracts
Samples: Sonus Pharmaceuticals Inc, Sonus Pharmaceuticals Inc
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - 4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.. ****Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Section 230.406
Appears in 2 contracts
Samples: License Agreement (Bison Capital Acquisition Corp.), License Agreement (Bison Capital Acquisition Corp.)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs Sections 4(a) - 4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 2 contracts
Samples: Supply Agreement (Magainin Pharmaceuticals Inc), Supply Agreement (Schein Pharmaceutical Inc)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceedingproceeding but may be amended by the neutral to the extent required to justly resolve the disputes related thereto. Except as expressly set forth in subparagraphs 4(a) - 4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 1 contract
Samples: Healthetech Inc
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceedingproceeding but may be amended by the neutral to the extent required to justly resolve the disputes related thereto. Except as expressly set forth in subparagraphs 4(a) - 4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production - admission of documents.
Appears in 1 contract
Samples: License Agreement (Healthetech Inc)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceedingproceeding but may be amended by the neutral to the extent required to justly resolve the disputes related thereto. Except as expressly set forth in subparagraphs 4(a) - 4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production admission of documents.
Appears in 1 contract
Samples: Medizintechnik Ag License Agreement (Healthetech Inc)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceedingproceeding but may be amended by the neutral to the extent required to justly resolve the disputes related thereto. Except as expressly set forth in subparagraphs 4(a) - 4(d4(a)—4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production admission of documents.
Appears in 1 contract
Samples: License Agreement (Healthetech Inc)
pages. This page limitation shall apply regardless of the number of issues ofissues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - 4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 1 contract
Samples: License Agreement
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceedingproceeding but may be amended by the neutral to the extent required to justly resolve the disputes related thereto. Except as expressly set forth in subparagraphs 4(a) - 4(d4(a)—4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production or—admission of documents.
Appears in 1 contract
Samples: License Agreement (Healthetech Inc)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - 4(d), no discovery shall be required or permitted by any means, 18 including depositionsdeposition, interrogatories, requests for admissions, admissions or production of documents.
Appears in 1 contract
Samples: Agreement Regarding Change in Control (Hospira Inc)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - — 4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents; provided however, that the neutral may order up to two depositions not to exceed three (3) hours in duration under exceptional circumstances. Any deposition ordered by the neutral shall be limited in scope and further limited in duration, if possible, so as to address only the exceptional circumstances that make the deposition necessary.
Appears in 1 contract
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs subparagraph 4(a) - 4(d), no discovery shall be required or permitted by any means, including depositions, interrogatoriesinterrogations, requests for admissions, or production of documents.
Appears in 1 contract
Samples: Development and Supply Agreement (Zymogenetics Inc)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs subsections 4(a) - 4(d), no discovery shall be required or permitted by any means, including depositionsdeposition, interrogatories, requests for admissions, or production of documents.
Appears in 1 contract
Samples: Agreement Regarding Change in Control (AbbVie Inc.)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a17.5(a) - 4(d17.5(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
Appears in 1 contract
